This article is part of the network’s archive of useful research information. This article is closed to new comments due to inactivity. We welcome new content which can be done by submitting an article for review or take part in discussions in an open topic or submit a blog post to take your discussions online.
Recorded 29 June 2015, Centre for Tropical Medicine and Global Health, University of Oxford
Professor Kevin Marsh
Senior Advisor, African Academy of Sciences and Professor of Tropical Medicine, University of Oxford
More about the topic: Malaria remains a major global health threat. At the end of the last century it was described as a public health disaster. In the last fifteen years there has been remarkable progress in reducing cases and deaths due to malaria. This has led to a welcome new optimism and a shift towards the idea of global elimination culminating in eradication. However the threats of underfinancing as well as emerging drug and insecticide resistance mean that many challenges remain to be overcome.
More about the speaker: Kevin Marsh is a senior advisor at the African Academy of Sciences and Professor of Tropical Medicine at the University of Oxford. From 1985-89 he was at the Institute of Molecular Medicine in Oxford and in 1989 established with colleagues a series of research projects on the clinical epidemiology and immunology of malaria in Kilifi on the Kenyan coast. These have subsequently developed into an international programme (the KEMRI Wellcome Trust Research Programme) of which he was director until August 2014. He is currently supporting the development of a new platform for the acceleration of science in Africa through the African Academy of Sciences. He is chair of the WHO Malaria Policy Advisory Committee and is a member of a number of international advisory committees relating to malaria and to global health research. He is a fellow of the Academy of Medical Sciences and was awarded the Prince Mahidol prize for medicine in 2010.